Weight in Lower Limbs Improves Gait Ataxia of in Machado-Joseph Disease Patients
Primary Purpose
Machado-Joseph Disease
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Weight in Lower Limbs
Sponsored by
About this trial
This is an interventional treatment trial for Machado-Joseph Disease focused on measuring SCA 3, Ataxic Gait
Eligibility Criteria
Inclusion Criteria:
- Patients should have between 18 and 65 years of age and independent gait
Exclusion Criteria:
- Were the need of assistive devices for walking ≤ 10m (such as crutches, wheelchairs and orthotics)
- Item gait of Scale for the Assessment and Rating of Ataxia (SARA)19≥, presence of other neurological disease that affect motor system
- Orthopedic impairments of lower limbs (fractures or surgeries in the past 6 months)
- Difference between the lower limbs greater than 3.0 cm
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm 3
Arm Type
Placebo Comparator
Other
Other
Arm Label
placebo Weight in Lower Limbs
0,5 kg Weight in Lower Limbs
1,0 kg Weight in Lower Limbs
Arm Description
placebo Weight in Lower Limbs
0,5 kg Weight in Lower Limbs
1,0 kg Weight in Lower Limbs
Outcomes
Primary Outcome Measures
Gait speed analysis [speed (mt/min) of walking for 10 meters away]
Secondary Outcome Measures
Gait cadence analysis [cadence (steps/min) of walking for 10 meters away]
Full Information
NCT ID
NCT02906046
First Posted
August 24, 2016
Last Updated
September 14, 2016
Sponsor
Federal University of Health Science of Porto Alegre
1. Study Identification
Unique Protocol Identification Number
NCT02906046
Brief Title
Weight in Lower Limbs Improves Gait Ataxia of in Machado-Joseph Disease Patients
Official Title
Weight in Lower Limbs Improves Gait Ataxia Of in Machado-Joseph Disease Patients: A Randomized Crossover Trial
Study Type
Interventional
2. Study Status
Record Verification Date
January 2013
Overall Recruitment Status
Completed
Study Start Date
April 2012 (undefined)
Primary Completion Date
February 2014 (Actual)
Study Completion Date
July 2014 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Federal University of Health Science of Porto Alegre
4. Oversight
5. Study Description
Brief Summary
Few studies evaluated the efficacy of adding weights on the lower limbs in patients with ataxic disorders. There is no current evidence on which would be the most appropriate weight for use in this context. To assess progress and benefits of using this load, gait of symptomatic carriers of spinocerebellar ataxia type 3/Machado Joseph disease the objective of the study is to evaluate the gait with and without different load weights on lower limbs. Outcomes were the Scale for the Assessment and Ataxia Rating of (SARA), kinematic gait assessment by the accelerometer and gyroscope and the Patient Global Impression (PGI) about which weight they prefer for walking.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Machado-Joseph Disease
Keywords
SCA 3, Ataxic Gait
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Masking
Investigator
Allocation
Randomized
Enrollment
20 (Actual)
8. Arms, Groups, and Interventions
Arm Title
placebo Weight in Lower Limbs
Arm Type
Placebo Comparator
Arm Description
placebo Weight in Lower Limbs
Arm Title
0,5 kg Weight in Lower Limbs
Arm Type
Other
Arm Description
0,5 kg Weight in Lower Limbs
Arm Title
1,0 kg Weight in Lower Limbs
Arm Type
Other
Arm Description
1,0 kg Weight in Lower Limbs
Intervention Type
Device
Intervention Name(s)
Weight in Lower Limbs
Primary Outcome Measure Information:
Title
Gait speed analysis [speed (mt/min) of walking for 10 meters away]
Time Frame
speed (mt/min) of walking for 10 meters away in 1min timeout
Secondary Outcome Measure Information:
Title
Gait cadence analysis [cadence (steps/min) of walking for 10 meters away]
Time Frame
cadence (steps/min) of walking for 10 meters away in 1min timeout
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Patients should have between 18 and 65 years of age and independent gait
Exclusion Criteria:
Were the need of assistive devices for walking ≤ 10m (such as crutches, wheelchairs and orthotics)
Item gait of Scale for the Assessment and Rating of Ataxia (SARA)19≥, presence of other neurological disease that affect motor system
Orthopedic impairments of lower limbs (fractures or surgeries in the past 6 months)
Difference between the lower limbs greater than 3.0 cm
12. IPD Sharing Statement
Learn more about this trial
Weight in Lower Limbs Improves Gait Ataxia of in Machado-Joseph Disease Patients
We'll reach out to this number within 24 hrs